Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for medical industry professionals · Thursday, October 18, 2018 · 465,499,440 Articles · 3+ Million Readers

Global Tuberculosis Diagnosis and Treatment Market Research and Forecast 2017-2022

Orion Market Research Pvt. Ltd.

Global Tuberculosis diagnosis and treatment market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2017-2022

INDORE, INDIA, March 8, 2018 /EINPresswire.com/ -- Orion Market Research (OMR), recently published a market research report on Global TB Market. According to OMR analysis, the global TB market is expected to grow at a CAGR 2.3% during 2017-2022. Global Tuberculosis diagnosis and treatment market is segmented on the basis of drugs, diagnosis, end users and regional outlook. Major players contributing to the growth of Global TB Market include Abbott Laboratories, Akonni Biosystems, Inc., Alere, Inc, Becton Dickinson, Bio - Synth Inc., bioMerieux Sa, Cepheid Inc, Eiken Chemical, Epistem Holdings Plc, F. Hoffmann-La Roche AG, GlaxoSmithKline. And so on. The report includes detailed & insightful chapters on market overview, key findings, strategic recommendations, methodology, market determinants, key strategies, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

The full report of global TB market is available https://www.omrglobal.com/industry-reports/tuberculosis-diagnosis-and-treatment-market/

“Reducing import duties on tuberculosis diagnostic equipment is predicted to go a long way and also making diagnostic tests more affordable across the globe.”

Tuberculosis is the leading cause of death from a single infectious agent across the globe. The present and future risk that TB poses to human health is mainly a consequence of the neglection of TB research field over the past several decades. However, to reverse this neglect and ending the tuberculosis disease by 2030, the United Nations Sustainable Development Goals (SDGs) and WHO End TB Strategy are taking decisive action with the support of all countries and stakeholders to increase TB research and innovation. Funding for research and development in the field of tuberculosis diagnosis and treatment will offer a huge opportunity for the global tuberculosis diagnosis and treatment market across the globe. Funding for R&D has been increasing significantly over past levels, and other institutional barriers to research and development have been resolved. The End TB Strategy specifies that new advanced development must be introduced by 2025 in order to reach the 2030 targets of a 90% reduction in TB deaths and 80% reduction in TB incidence compared with 2015 levels. This goal will significantly contribute to the growth of the global market.

On the basis of the geography, TB diagnosis and treatment market has been segmented into North America, Asia Pacific, Europe and Rest of the World. APAC has been predicted to dominate the global tuberculosis market and will be the fastest growing region during the forecast period. The major cause of this dominance is the rising incidence and prevalence of tuberculosis in the region along with increasing government initiatives. As per World Health Organization, the largest number of new TB cases was recorded in Asia, accounting about 45% of new cases in the region.

Companies profiled in the report:
• Abbott Laboratories
• Akonni Biosystems, Inc.
• Alere, Inc.
• Becton Dickinson and Co.
• Bio – Synth Inc.
• Biomérieux SA
• Cepheid Inc
• Eiken Chemical Co. Ltd.
• Epistem Holdings PLC
• F. Hoffmann-La Roche AG
• Hain Lifesciences Gmbh
• Hologic Corporation
• Glaxosmithkline
• Labatec Pharma SA
• Lupin
• Otsuka Novel Products GmbH
• Qiagen
• Sandoz
• Sanofi
• Thermo Fisher Scientific, Inc

For related reports please https://www.omrglobal.com/reports-category/pharmaceuticals/

The report covers:
• Comprehensive research methodology of Global TB market.
• In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global TB market.
• Insights about market determinants which are stimulating the TB market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.

About Orion Market Research
Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, Company Profiling, consulting and other research-based services. OMR provides global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provides a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here

Powered by EIN Presswire